Page 3 - கிளீவ்லேண்ட் சிகிச்சையகம் லெர்னர் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
New study points to novel drug target for treating COVID-19
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Cleveland Clinic, NFLPA team up for brain health initiative
wkyc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkyc.com Daily Mail and Mail on Sunday newspapers.
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology
Technology invented and developed at Cleveland Clinic
News provided by
Share this article
Share this article
SAN JOSE, Calif., March 12, 2021 /PRNewswire/ Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the European Patent Office has issued and published the first European patent for its novel ovarian cancer vaccine technology. This technology was invented and developed at Cleveland Clinic and Anixa is the worldwide licensee.
The patent is titled, Ovarian Cancer Vaccines, and the inventors are Drs. Vincent K. Tuohy, Suparna Mazumder, and Justin M. Johnson, all of Cleveland Clinic.
E-Mail
IMAGE: A research team led by Dr. Thaddeus Stappenbeck of Cleveland Clinic Lerner Research Institute has discovered a new tissue infection associated with Crohn s disease. view more
Credit: Cleveland Clinic
March 11, 2021, CLEVELAND: A Cleveland Clinic-led team of researchers has discovered a new tissue infection associated with Crohn s disease. According to study results published in
Science, a type of yeast commonly found in cheese and processed meat is elevated in areas of unhealed wounds in Crohn s disease patients, a discovery that may point to new treatment or prevention approaches for the common inflammatory bowel disease.
The work was led by Thaddeus Stappenbeck, M.D., PhD., chair of Cleveland Clinic Lerner Research Institute s Department of Inflammation and Immunity. The team, which also included researchers from Washington University, Cedars-Sinai Medical Center and Dartmouth College, found that levels of the yeast Debaryomyces hansenii are higher
A Common Yeast May Cause Trouble For Crohn s Patients
gizmodo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gizmodo.com Daily Mail and Mail on Sunday newspapers.